NCT06466915View on ClinicalTrials.gov

Propofol vs. Nasal Dexmedetomidine in Pediatric Agitation and Delirium

PHASE4CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Comparison of the Effects of Propofol and Nasal Dexmedetomidine
Interventions
DRUG

Dexmedetomidine

Group Dex received 1 mcg/kg of dexmedetomidine intra-nasal 10 minutes before the surgical procedure ended.

DRUG

Propofol

Group Pofol received 1 mg/kg propofol IV before the extubation.

Trial Locations (1)

06490

Ahmed Uslu, Ankara

All Listed Sponsors
lead

Baskent University Ankara Hospital

OTHER

NCT06466915 - Propofol vs. Nasal Dexmedetomidine in Pediatric Agitation and Delirium | Biotech Hunter | Biotech Hunter